PIPELINE

Pipeline

Substance Indications Candidate materials Non-clinical Phase 1
clinical trial
Phase 2
clinical trial
Phase 3
clinical trial
Item authorization
Allogeneic osteoblast therapy agent (CF-M801) Osteonecrosis ofthe Femoral Head
OsteoporoticFracture
Spinal fusion
SteroidalOsteonecrosisof the Femoral Head
Cell therapy agent(DR-NK) anticancer immunity Blood cancer
Solid cancer